Has the time come for genomic tests to guide the use of adjuvant chemotherapy in node-positive breast cancer?

被引:2
作者
Azim, H. A., Jr. [1 ]
机构
[1] Univ Libre Bruxelles, Inst Jules Bordet, Breast Canc Translat Res Lab BCTL, Brussels, Belgium
关键词
DISTANT RECURRENCE; GENE-EXPRESSION; WOMEN; SCORE; ASSAY; RISK; IHC4;
D O I
10.1093/annonc/mdv248
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1521 / 1523
页数:3
相关论文
共 16 条
  • [1] Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
    Albain, K.
    Anderson, S.
    Arriagada, R.
    Barlow, W.
    Bergh, J.
    Bliss, J.
    Buyse, M.
    Cameron, D.
    Carrasco, E.
    Clarke, M.
    Correa, C.
    Coates, A.
    Collins, R.
    Costantino, J.
    Cutter, D.
    Cuzick, J.
    Darby, S.
    Davidson, N.
    Davies, C.
    Davies, K.
    Delmestri, A.
    Di Leo, A.
    Dowsett, M.
    Elphinstone, P.
    Evans, V.
    Ewertz, M.
    Gelber, R.
    Gettins, L.
    Geyer, C.
    Goldhirsch, A.
    Godwin, J.
    Gray, R.
    Gregory, C.
    Hayes, D.
    Hill, C.
    Ingle, J.
    Jakesz, R.
    James, S.
    Kaufmann, M.
    Kerr, A.
    MacKinnon, E.
    McGale, P.
    McHugh, T.
    Norton, L.
    Ohashi, Y.
    Paik, S.
    Pan, H. C.
    Perez, E.
    Peto, R.
    Piccart, M.
    [J]. LANCET, 2012, 379 (9814) : 432 - 444
  • [2] Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
    Albain, Kathy S.
    Barlow, William E.
    Shak, Steven
    Hortobagyi, Gabriel N.
    Livingston, Robert B.
    Yeh, I-Tien
    Ravdin, Peter
    Bugarini, Roberto
    Boehner, Frederick L.
    Davidson, Nancy E.
    Sledge, George W.
    Winer, Eric P.
    Hudis, Clifford
    Ingle, James N.
    Perez, Edith A.
    Pritchard, Kathleen I.
    Shepherd, Lois
    Gralow, Julie R.
    Yoshizawa, Carl
    Allred, D. Craig
    Osborne, C. Kent
    Hayes, Daniel F.
    [J]. LANCET ONCOLOGY, 2010, 11 (01) : 55 - 65
  • [3] Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement
    Azim, H. A., Jr.
    Michiels, S.
    Zagouri, F.
    Delaloge, S.
    Filipits, M.
    Namer, M.
    Neven, P.
    Symmans, W. F.
    Thompson, A.
    Andre, F.
    Loi, S.
    Swanton, C.
    [J]. ANNALS OF ONCOLOGY, 2013, 24 (03) : 647 - 654
  • [4] Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial
    Bonnefoi, H.
    Litiere, S.
    Piccart, M.
    MacGrogan, G.
    Fumoleau, P.
    Brain, E.
    Petit, T.
    Rouanet, P.
    Jassem, J.
    Moldovan, C.
    Bodmer, A.
    Zaman, K.
    Cufer, T.
    Campone, M.
    Luporsi, E.
    Malmstrom, P.
    Werutsky, G.
    Bogaerts, J.
    Bergh, J.
    Cameron, D. A.
    [J]. ANNALS OF ONCOLOGY, 2014, 25 (06) : 1128 - 1136
  • [5] Comparison of PAM50 Risk of Recurrence Score With Oncotype DX and IHC4 for Predicting Risk of Distant Recurrence After Endocrine Therapy
    Dowsett, Mitch
    Sestak, Ivana
    Lopez-Knowles, Elena
    Sidhu, Kalvinder
    Dunbier, Anita K.
    Cowens, J. Wayne
    Ferree, Sean
    Storhoff, James
    Schaper, Carl
    Cuzick, Jack
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (22) : 2783 - +
  • [6] A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors
    Filipits, Martin
    Rudas, Margaretha
    Jakesz, Raimund
    Dubsky, Peter
    Fitzal, Florian
    Singer, Christian F.
    Dietze, Otto
    Greil, Richard
    Jelen, Andrea
    Sevelda, Paul
    Freibauer, Christa
    Mueller, Volkmar
    Jaenicke, Fritz
    Schmidt, Marcus
    Koelbl, Heinz
    Rody, Achim
    Kaufmann, Manfred
    Schroth, Werner
    Brauch, Hiltrud
    Schwab, Matthias
    Fritz, Peter
    Weber, Karsten E.
    Feder, Inke S.
    Hennig, Guido
    Kronenwett, Ralf
    Gehrmann, Mathias
    Gnant, Michael
    [J]. CLINICAL CANCER RESEARCH, 2011, 17 (18) : 6012 - 6020
  • [7] Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype
    Gnant, M.
    Sestak, I.
    Filipits, M.
    Dowsett, M.
    Balic, M.
    Lopez-Knowles, E.
    Greil, R.
    Dubsky, P.
    Stoeger, H.
    Rudas, M.
    Jakesz, R.
    Ferree, S.
    Cowens, J. W.
    Nielsen, T.
    Schaper, C.
    Fesl, C.
    Cuzick, J.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 (08) : 1685 - 1691
  • [8] The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer
    Knauer, Michael
    Mook, Stella
    Rutgers, Emiel J. T.
    Bender, Richard A.
    Hauptmann, Michael
    van de Vijver, Marc J.
    Koornstra, Rutger H. T.
    Bueno-de-Mesquita, Jolien M.
    Linn, Sabine C.
    van't Veer, Laura J.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2010, 120 (03) : 655 - 661
  • [9] A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
    Paik, S
    Shak, S
    Tang, G
    Kim, C
    Baker, J
    Cronin, M
    Baehner, FL
    Walker, MG
    Watson, D
    Park, T
    Hiller, W
    Fisher, ER
    Wickerham, DL
    Bryant, J
    Wolmark, N
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (27) : 2817 - 2826
  • [10] Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer
    Paik, Soonmyung
    Tang, Gong
    Shak, Steven
    Kim, Chungyeul
    Baker, Joffre
    Kim, Wanseop
    Cronin, Maureen
    Baehner, Frederick L.
    Watson, Drew
    Bryant, John
    Costantino, Joseph P.
    Geyer, Charles E., Jr.
    Wickerham, D. Lawrence
    Wolmark, Norman
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (23) : 3726 - 3734